Vitamin D effects on B cell function in autoimmunity

Annals of the New York Academy of Sciences

Volumn 1317, Issue 1, 2014, Pages 84-91

  Rolf, Linda ^a,b   Muris, Anne Hilde ^a,b   Hupperts, Raymond ^a,b   Damoiseaux, Jan ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Zuyderland Medical Centre   (Netherlands)

Author keywords

Autoimmune diseases; B cell function; Interleukin 10; Regulatory B cell; Vitamin D

Indexed keywords

ANTIBODY; COLECALCIFEROL; CYTOCHROME P450; CYTOCHROME P450 24A1; CYTOCHROME P450 27B1; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D BINDING PROTEIN; VITAMIN D RECEPTOR;

ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; HOMEOSTASIS; HUMAN; IMMUNE SYSTEM; LYMPHOCYTE FUNCTION; MULTIPLE SCLEROSIS; NONHUMAN; PATHOPHYSIOLOGY; PLASMA CELL; RECEPTOR UPREGULATION; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; ULTRAVIOLET B RADIATION; VITAMIN D METABOLISM; VITAMIN D RESPONSIVE ELEMENT;

AUTOIMMUNE DISEASES; B CELL FUNCTION; INTERLEUKIN-10; REGULATORY B CELL; VITAMIN D;

ANIMALS; ANTIBODY FORMATION; AUTOIMMUNE DISEASES; AUTOIMMUNITY; B-LYMPHOCYTES; HOMEOSTASIS; HUMANS; VITAMIN D;

EID: 84901506834     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12440     Document Type: Article

References (54)

1. Bouillon, R. et al. 2008. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr. Rev. 29: 726-776.
2. Girgis, C.M. et al. 2013. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr. Rev. 34: 33-83.
3. Christakos, S. et al. 2013. Vitamin D: beyond bone. Ann. N.Y. Acad. Sci. 1287: 45-58.
4. Smolders, J. & J. Damoiseaux 2011. Vitamin D as a T-cell modulator in multiple sclerosis. Vitam. Horm. 86: 401-428.
5. Lips, P. 2001. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr. Rev. 22: 477-501.
6. Holick, M.F. 2007. Vitamin D deficiency. N. Engl. J. Med. 357: 266-281.
7. Chen, S. et al. 2007. Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 179: 1634-1647.
8. Peelen, E. et al. 2011. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun. Rev. 10: 733-743.
9. Farrugia, M.E. & A. Vincent 2010. Autoimmune mediated neuromuscular junction defects. Curr. Opin. Neurol. 23: 489-495.
10. Damoiseaux, J. 2013. Bullous skin diseases: classical types of autoimmune diseases. Scientifica 2013: 1-5.
11. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
12. Van Leeuwen, M. et al. 2009. The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis. Autoimmun. Rev. 9: 53-57.
13. Edwards, J.C. & G. Cambridge 2006. B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nat. Rev. Immunol. 6: 394-403.
14. Hampe, C.S. 2012. B cell in autoimmune diseases. Scientifica 2012: 1-18.
15. Kalampokis, I. et al. 2013. IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. Arthritis Res. Ther. 15(Suppl 1): S1.
16. Mauri, C. & A. Bosma 2012. Immune regulatory function of B cells. Annu. Rev. Immunol. 30: 221-241.
17. Fillatreau, S. et al. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
18. Mauri, C. et al. 2003. Prevention of arthritis by interleukin 10-producing B cells. J. Exp. Med. 197: 489-501.
19. Kitamura, D. et al. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423-426.
20. Sun, J.B. et al. 2008. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. J. Immunol. 181: 8278-8287.
21. Carter, N.A. et al. 2011. Mice lacking endogenous IL-10-producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1/Th17 but a decrease in regulatory T cells. J. Immunol. 186: 5569-5579.
22. Blair, P.A. et al. 2010. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 32: 129-140.
23. Duddy, M. et al. 2007. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178: 6092-6099.
24. Knippenberg, S. et al. 2011. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission. J. Neuroimmunol. 239: 80-86.
25. Sun, F. et al. 2014. Interleukin-10 producing-B cells and their association with responsiveness to rituximab in myasthenia gravis. Muscle Nerve 49: 487-94.
26. Holick, M.F. 2003. Vitamin D: a millenium perspective. J. Cell. Biochem. 88: 296-307.
27. Seamans, K.M. & K.D. Cashman 2009. Existing and potentially novel functional markers of vitamin D status: a systematic review. Am. J. Clin. Nutr. 89: 1997S-2008S.
28. Nykjaer, A. et al. 1999. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96: 507-515.
29. Smolders, J. et al. 2009. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun. Rev. 8: 621-626.
30. Prosser, D.E. & G. Jones 2004. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem. Sci. 29: 664-673.
31. Damoiseaux, J. 2006. Regulatory T cells: back to the future. Neth. J. Med. 64: 4-9.
32. Jeffery, L.E. et al. 2012. Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses. J. Immunol. 189: 5155-5164.
33. Smolders, J. et al. 2011. Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis. J. Neuroimmunol. 235: 91-97.
34. Morgan, J.W. et al. 2000. Vitamin D-mediated gene regulation in phenotypically defined human B cell subpopulations. Endocrinology 141: 3225-3234.
35. Heine, G. et al. 2008. 1, 25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur. J. Immunol. 38: 2210-2218.
36. Lemire, J.M. et al. 1984. 1 alpha, 25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J. Clin. Invest. 74: 657-661.
37. Chen, W.C. et al. 1987. 1, 25-Dihydroxyvitamin D3-mediated inhibition of human B cell differentiation. Clin. Exp. Immunol. 69: 639-646.
38. Muller, K. et al. 1991. The role of monocytes and T cells in 1, 25-dihydroxyvitamin D3 mediated inhibition of B cell function in vitro. Immunopharmacology 21: 121-128.
39. Lugar, P.L. et al. 2012. Molecular characterization of circulating plasma cells in patients with active systemic lupus erythematosus. PLoS One 7: e44362.
40. Provvedini, D.M. et al. 1986. 1 alpha, 25-Dihydroxyvitamin D3-binding macromolecules in human B lymphocytes: effects on immunoglobulin production. J. Immunol. 136: 2734-2740.
41. Iho, S. et al. 1986. The effect of 1, 25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J. Immunol. 136: 4427-4431.
42. Hartmann, B. et al. 2011. Targeting the vitamin D receptor inhibits the B cell-dependent allergic immune response. Allergy 66: 540-548.
43. Heine, G. et al. 2002. 1alpha, 25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Eur. J. Immunol. 32: 3395-3404.
44. Matheu, V. et al. 2003. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J. Allergy Clin. Immunol. 112: 585-592.
45. Gupta, A. et al. 2011. Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. Am. J. Respir. Crit. Care Med. 184: 1342-1349.
46. Sharief, S. et al. 2011. Vitamin D levels and food and environmental allergies in the United States: results from the National Health and Nutrition Examination Survey 2005-2006. J. Allergy Clin. Immunol. 127: 1195-1202.
47. Kang, J.W. et al. 2014. The association between serum vitamin D level and immunoglobulin E in Korean adolescents. Int. J. Pediatr. Otorhinolaryngol. 78: 817-820.
48. Hypponen, E. et al. 2009. Serum 25-hydroxyvitamin D and IgE-a significant but nonlinear relationship. Allergy 64: 613-620.
49. Ozcan, E. et al. 2008. Primary immune deficiencies with aberrant IgE production. J. Allergy Clin. Immunol. 122: 1054-1062.
50. Knippenberg, S. et al. 2011. Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis. Mult. Scler. 17: 1418-1423.
51. Terrier, B. et al. 2012. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res. Ther. 14: R221.
52. Peelen, E. et al. 2013. Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 32: 61-69.
53. Nashold, F.E. et al. 2001. Rag-1-dependent cells are necessary for 1, 25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 119: 16-29.
54. Spach, K.M. et al. 2006. IL-10 signaling is essential for 1, 25-dihydroxyvitamin D3-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 177: 6030-6037.